A Solute Carrier Family 22 Member 3 Variant rs3088442 G→A Associated with Coronary Heart Disease Inhibits Lipopolysaccharide-induced Inflammatory Response*
暂无分享,去创建一个
Suli Huang | X. Miao | Tangchun Wu | M. He | Lu Li | Li Zhou | Xiayun Dai | Tian Wang | Fangqin Wu
[1] Yu Fan,et al. Suppression of metastasis of human pancreatic cancer cells to the liver by small interfering RNA-mediated targeting of the midkine gene , 2013, Oncology letters.
[2] G. Zhao,et al. The human MTHFR rs4846049 polymorphism increases coronary heart disease risk through modifying miRNA binding. , 2013, Nutrition, metabolism, and cardiovascular diseases : NMCD.
[3] Yan Liu,et al. MicroRNA-638 is highly expressed in human vascular smooth muscle cells and inhibits PDGF-BB-induced cell proliferation and migration through targeting orphan nuclear receptor NOR1. , 2013, Cardiovascular research.
[4] J. Zavadil,et al. Control of Cholesterol Metabolism and Plasma High-Density Lipoprotein Levels by microRNA-144 , 2013, Circulation research.
[5] Yu Du,et al. MicroRNAs 185, 96, and 223 Repress Selective High-Density Lipoprotein Cholesterol Uptake through Posttranscriptional Inhibition , 2013, Molecular and Cellular Biology.
[6] A. Schober,et al. MicroRNA-126, -145, and -155: a therapeutic triad in atherosclerosis? , 2013, Arteriosclerosis, thrombosis, and vascular biology.
[7] Jinmai Jiang,et al. The human angiotensin II type 1 receptor +1166 A/C polymorphism attenuates microRNA-155 binding. , 2013, The Journal of Biological Chemistry.
[8] S. Shevkoplyas,et al. Histamine reduces GPIbα-mediated adhesion of platelets to TNF-α-activated vascular endothelium. , 2013, Thrombosis research.
[9] Z. Yin,et al. Gu-4 Suppresses Affinity and Avidity Modulation of CD11b and Improves the Outcome of Mice with Endotoxemia and Sepsis , 2012, PloS one.
[10] L. Qi,et al. Genetic variants, plasma lipoprotein(a) levels, and risk of cardiovascular morbidity and mortality among two prospective cohorts of type 2 diabetes. , 2012, European heart journal.
[11] J. Launay,et al. Downregulation of basophil-derived IL-4 and in vivo T(H)2 IgE responses by serotonin and other organic cation transporter 3 ligands. , 2011, The Journal of allergy and clinical immunology.
[12] R. Vasan,et al. Genetic and Clinical Correlates of Early-Outgrowth Colony-Forming Units , 2011, Circulation. Cardiovascular genetics.
[13] Y. Sasaguri,et al. Histamine Deficiency Decreases Atherosclerosis and Inflammatory Response in Apolipoprotein E Knockout Mice Independently of Serum Cholesterol Level , 2011, Arteriosclerosis, thrombosis, and vascular biology.
[14] Swati S. More,et al. Role of organic cation transporter 3 (SLC22A3) and its missense variants in the pharmacologic action of metformin , 2010, Pharmacogenetics and genomics.
[15] Hongbing Shen,et al. Functional promoter -1271G>C variant of HSPB1 predicts lung cancer risk and survival. , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[16] T. V. van Berkel,et al. The peripheral blood mononuclear cell microRNA signature of coronary artery disease. , 2010, Biochemical and biophysical research communications.
[17] G. Pasterkamp,et al. Toll like receptor 4 in atherosclerosis and plaque destabilization. , 2010, Atherosclerosis.
[18] D. Keppler,et al. Expression of organic cation transporters OCT1 (SLC22A1) and OCT3 (SLC22A3) is affected by genetic factors and cholestasis in human liver , 2009, Hepatology.
[19] E. Abraham,et al. miR-147, a microRNA that is induced upon Toll-like receptor stimulation, regulates murine macrophage inflammatory responses , 2009, Proceedings of the National Academy of Sciences.
[20] Benjamin J. Wright,et al. Genome-wide haplotype association study identifies the SLC22A3-LPAL2-LPA gene cluster as a risk locus for coronary artery disease , 2009, Nature Genetics.
[21] D. Stechschulte,et al. Histamine Directly and Synergistically with Lipopolysaccharide Stimulates Cyclooxygenase-2 Expression and Prostaglandin I2 and E2 Production in Human Coronary Artery Endothelial Cells1 , 2007, Journal of Immunology.
[22] Thomas D. Schmittgen,et al. The Human Angiotensin II Type 1 Receptor +1166 A/C Polymorphism Attenuates MicroRNA-155 Binding* , 2007, Journal of Biological Chemistry.
[23] R. Thurmond,et al. Organic cation transporter 3 modulates murine basophil functions by controlling intracellular histamine levels , 2005, The Journal of experimental medicine.
[24] F. Cambien,et al. Adverse Associations Between CX3CR1 Polymorphisms and Risk of Cardiovascular or Cerebrovascular Disease , 2005, Arteriosclerosis, thrombosis, and vascular biology.
[25] Dao-Yi Yu,et al. Histamine Induces Opposing Vasoactive Effects at Different Levels of the Ocular Vasculature , 2005, Current eye research.
[26] K. Sunagawa,et al. Bone Marrow–Derived Monocyte Chemoattractant Protein-1 Receptor CCR2 Is Critical in Angiotensin II–Induced Acceleration of Atherosclerosis and Aneurysm Formation in Hypercholesterolemic Mice , 2004, Arteriosclerosis, thrombosis, and vascular biology.
[27] M. Hirai,et al. CD14 promoter polymorphism is associated with acute myocardial infarction resulting from insignificant coronary artery stenosis , 2003, Heart.
[28] J. Pober,et al. Histamine Antagonizes Tumor Necrosis Factor (TNF) Signaling by Stimulating TNF Receptor Shedding from the Cell Surface and Golgi Storage Pool* , 2003, Journal of Biological Chemistry.
[29] A. Montgomery,et al. Involvement of integrin alpha(v)beta(3) and cell adhesion molecule L1 in transendothelial migration of melanoma cells. , 2001, Molecular biology of the cell.
[30] P. Libby,et al. Absence of monocyte chemoattractant protein-1 reduces atherosclerosis in low density lipoprotein receptor-deficient mice. , 1998, Molecular cell.
[31] M. Joseph,et al. Histamine induces IL‐6 production by human endothelial cells , 1994, Clinical and experimental immunology.
[32] A. Montgomery,et al. Involvement of Integrin v 3 and Cell Adhesion Molecule L1 in Transendothelial Migration of Melanoma Cells , 2001 .